Comparison of protein with DNA therapy for chronic myocardial ischemia using fibroblast growth factor-2

By Heilmann C.   von Samson P.   Schlegel K.   Attmann T.   von Specht B.-U.   Beyersdorf F.   Lutter G.  

European Journal of Cardio-Thoracic Surgery, Vol. 22, Iss. 6, 2002-12 ,pp. : 957-964

Elsevier

Access to resources Recommend Favorite

Early and late outcome after CABG in patients with evolving myocardial infarction

By Sergeant P.   Blackstone E.   Meyns B.  

European Journal of Cardio-Thoracic Surgery, Vol. 11, Iss. 5, 1997-05 ,pp. : 848-856

Elsevier

Access to resources Recommend Favorite

Risk Factors of Postoperative Myocardial Infarction after Colorectal Surgeries

By Moghadamyeghaneh Zhobin   Mills Steven D.   Carmichael Joseph C.   Pigazzi Alessio   Stamos Michael J.  

The American Surgeon, Vol. 81, Iss. 4, 2015-04 ,pp. : 358-364

Southeastern Surgical Congress

Access to resources Recommend Favorite

Local application of basic fibroblast growth factor increases the risk of local infection after trauma: An in-vitro and in-vivo study in rats

By Kälicke Thomas   Köller Manfred   Frangen Thomas Manfred   Schlegel Urs   Sprutacz Oliver   Printzen Gert   Muhr Gert   Arens Stephan  

Acta Orthopaedica, Vol. 78, Iss. 1, 2007-02 ,pp. : 63-73

Informa Healthcare

Access to resources Recommend Favorite

Urinary excretion of alpha1-microglobulin and albumin in acute myocardial infarction

By Holm Jan   Ravn Jakob   Ingemann Hansen Steen  

Scandinavian Journal of Urology and Nephrology, Vol. 40, Iss. 4, 2006-09 ,pp. : 339-344

Informa Healthcare

Access to resources Recommend Favorite